Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2022

Primary Completion Date

May 30, 2026

Study Completion Date

December 25, 2026

Conditions

Non Alcoholic SteatohepatitisHyperuricemia

Interventions

DRUG

Febuxostat 80 MG Oral Tablet

Febuxostat used as 80 mg oral tablet once daily for 6 months

DRUG

vit E

Vitamin E used as 400 mg soft gelatin capsules twice daily for 6 months

Trial Locations (1)

Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine,Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER